EICHOR
● Completed
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma · Sponsor: Coherus Oncology, Inc.
About this study
This is a Phase 2 trial composed of an open label Lead-In followed by a Randomized Phase designed to evaluate the efficacy and safety of SRF388 in combination with atezolizumab plus bevacizumab compared to placebo (inactive substance) in combination with atezolizumab plus bevacizumab in patients with first-line advanced or metastatic HCC.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (37)
| University of Arizona Cancer Center - North Campus | Tucson, Arizona, United States | — |
| City of Hope | Duarte, California, United States | — |
| University of Southern California - Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| University of Florida Health Science Center - Gainesville | Gainesville, Florida, United States | — |
| University of Miami, Sylvester Comprehensive Cancer Center | Miami, Florida, United States | — |
| Louisville VA Medical Center - Robley Rex VA Medical Center | Louisville, Kentucky, United States | — |
| Veterans Affairs Ann Arbor Healthcare System | Ann Arbor, Michigan, United States | — |
| University of Michigan Health System (UMHS) | Ann Arbor, Michigan, United States | — |
| Henry Ford Hospital | Detroit, Michigan, United States | — |
| Veterans Affairs New York Harbor Healthcare System - Manhattan VA Medical Center | New York, New York, United States | — |
| NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center (NYU Cancer Institute (NYUCI)) | New York, New York, United States | — |
| University of Oklahoma Health Sciences Center - Stephenson Cancer Center | Oklahoma City, Oklahoma, United States | — |
+ 25 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05359861